The quarterly will only report on things up to 30/06/2014 unless something startling happens during the course of its preparation.
Obviously no contracts have been signed and there would not appear to be any startling income generated from existing contracts as that information could be imparted without any "breach of confidentiality" which apparently stops the company from providing specific information. All it simply lets them tell us is that everything is going well, new tests are being done, more parties are displaying interest but no one is prepared to sign a contract and pay for the use of this "disruptive technology" that can be used in so many tests and so many different fields that its share price should be closer to $20 than 20 cents.
I believe that concrete results should already have been achieved and they have engaged consultants to help them sort out and negotiate some meaningful deals for which contracts can be signed. We were perilously close to a company making deal 4 years ago and we are still waiting.
I do not believe that the deal that was perilously close 4 years ago is the same deal(s) that the company is working on now so what has happened to that deal. If it did not and will not eventuate surely GC can reveal the name of the party involved as I believe that the confidentiality would only apply to ongoing, but as yet, unfinalised deals.
It is now time for more specific information to be disclosed apart from saying all is still going well but we haven't got anywhere yet.
- Forums
- ASX - By Stock
- ADO
- Interesting interview re Minicare system
ADO
anteotech ltd
Add to My Watchlist
0.00%
!
1.3¢

Interesting interview re Minicare system, page-32
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.16M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $10.88K | 843.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 246504 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 2711219 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1901789 | 0.012 |
9 | 2353674 | 0.011 |
8 | 3709000 | 0.010 |
10 | 1803777 | 0.009 |
10 | 3571875 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 2711219 | 8 |
0.015 | 4089116 | 12 |
0.016 | 1475197 | 3 |
0.017 | 218695 | 4 |
0.018 | 499000 | 3 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online